Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured in The New York Times, the study opens new discussions about screening opportunities.
Article links:
Dru Smith, an interstitial lung disease patient, shares his experience and care journey. Reston resident…
Tuesday, Oct. 27 Leesburg, VA, — As part of the national Stop the Bleed® campaign,…
Hospital opened in 1976 as a 76-bed community hospital and has grown into a regional…
Cecilia Young, MD is a board-certified internal medicine physician with more than 30 years of…
Leesburg, VA, Sept. 28, 2026 — Inova Blood Donor Services invites the Loudoun County community…
Experienced Inova leader brings nearly two decades of clinical and executive leadership to Loudoun Leesburg,…